The forecasted sales for the cardiovascular system medicine market in Türkiye from 2024 to 2028 show a gradual decline. The year-on-year variations are as follows:
- From 2024 to 2025: -1.53%
- From 2025 to 2026: -1.30%
- From 2026 to 2027: -1.09%
- From 2027 to 2028: -0.94%
Over the last 5 years, the Compound Annual Growth Rate (CAGR) is -1.22%, indicating a consistent reduction in sales.
Future trends to watch in the cardiovascular system medicine market in Türkiye include potential market saturation, advancements in alternative treatments, and the impact of healthcare policies and economic conditions on pharmaceutical expenditures. Continued monitoring of these factors can provide deeper insights into market dynamics.
